GFPT2 controls immune evasion in EGFR-mutated non-small cell lung cancer

Jiali Liu(China Pharmaceutical University), Fang Zhou(China Pharmaceutical University), Haobin Li(China Pharmaceutical University), Wenjing Jia(Qinghai Tibetan Hospital), Chenghao Fu(Nanjing Medical University), Luyao Ao(China Pharmaceutical University), Xin Shang(China Pharmaceutical University), Yantong Li(Shenyang Pharmaceutical University), Feiyi Wang(China Three Gorges University), Jun Wang(Jiangnan University), Ruiqi Wang(Sun Yat-sen University), Wei Jia(Sichuan University), Jiawen Cui(China Pharmaceutical University), Ying Yu(Anhui Medical University), Shencun Fang(Nanjing Chest Hospital), Qixing Gong(Jiangsu Province Hospital), Guangji Wang(China Pharmaceutical University)
Research Square
April 26, 2024
10.21203/rs.3.rs-4203208/v1
Cited by 1

Related Papers

Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome
|Alzheimer s & Dementia|2018|690
Genome sequence of the progenitor of wheat A subgenome Triticum urartu
|Nature|2018|524
Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers
|Alzheimer s & Dementia|2018|340
Hydrogen Sulfide Induces Keap1 S-sulfhydration and Suppresses Diabetes-Accelerated Atherosclerosis via Nrf2 Activation
|Diabetes|2016|334
A Metabolite Array Technology for Precision Medicine
|Analytical Chemistry|2021|285